A Novel ex-vivo platform for personalized treatment in metastatic ovarian cancer.
Alain Valdivia, Adebimpe Adefolaju, Morrent Thang, Luz Andrea Cuaboy, Catherine S. John, Breanna Mann, Andrew Satterlee, Victoria Lin Bae-Jump, Shawn Hingtgen
This study develops an ex-vivo platform using rat mesenteric membranes to assess treatment response in ovarian cancer, showing correlation with clinical outcomes.
bioRxiv · Mar 14, 2024 · PreprintCancer Biology